CAMBRIDGE, Mass., Sept. 30, 2025 /PRNewswire/ -- Clear Scientific Inc., a clinical stage biopharmaceutical company focused on the development of first-in-class small molecules to reverse acute ...
Methamphetamine (METH) abuse is a major health concern. Understanding how METH interacts with its target proteins is crucial for the development of novel medications to address drug addiction.
A phase 2 trial evaluating CS-1103 in participants with methamphetamine use disorder is expected to begin in the first quarter of 2026. The Food and Drug Administration (FDA) has granted Fast Track ...
The process of making synthetic drugs involves various steps, but it must include a key ingredient called a precursor. For methamphetamine, these precursors are 1-phenyl-2-propanone (P2P) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback